<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The use of in vivo alternative models in order to perform toxicological tests is increasing [
 <xref rid="B15-medicina-55-00194" ref-type="bibr" class="xref">15</xref>,
 <xref rid="B40-medicina-55-00194" ref-type="bibr" class="xref">40</xref>]. In this scenario, several model organisms have been used to identify the pharmacological properties of plants material or active components. 
 <italic class="italic">Drosophila melanogaster</italic> is one of them, and has been used for more than 110 years to study the biological effects of compounds and the underlying pathophysiology of numerous diseases, including Alzheimer’s and Parkinson’s diseases [
 <xref rid="B31-medicina-55-00194" ref-type="bibr" class="xref">31</xref>,
 <xref rid="B41-medicina-55-00194" ref-type="bibr" class="xref">41</xref>,
 <xref rid="B42-medicina-55-00194" ref-type="bibr" class="xref">42</xref>].
</p>
